Q4 2023 Holdings
Filed 2024-02-12 | 5 holdings | $238.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Arcellx Inc.(ACLX) | COMMON STOCK | 03940C100 | $174.6M | 3,146,630 | 73.3% |
| ARS Pharmaceuticals(SPRY) | COM | 82835W108 | $22.0M | 4,012,903 | 9.2% |
| Design Therapeutics Inc(DSGN) | COM | 25056L103 | $17.3M | 6,526,476 | 7.3% |
| Mineralys Therapeutics(MLYS) | COM | 603170101 | $15.4M | 1,794,600 | 6.5% |
| Nkarta Inc.(NKTX) | COM | 65487U108 | $8.8M | 1,333,333 | 3.7% |